ArticleScientific reports2025
Impact of dietary pomegranate peel biochar on performance and economics of Nile tilapia (Oreochromis niloticus).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study sought to ascertain the actual effects of different dietary levels of pomegranate peel biochar on the performance, antioxidant capacity, intestinal and liver histology, and expression of growth, antioxidant, and immune-related genes, as well as the economics of Nile tilapia (Oreochromis niloticus). One hundred and twenty fingerlings (3.15 ± 0.15 g/fish) were randomly distributed into 4 triplicate groups (10 fish/replicate). The pomegranate peel was added to the fish diet at 1, 3, and 5 g/kg diet as Bp1%, Bp3%, and Bp5%. They were given to Nile tilapia for 60 days. Fish fed a diet supplemented with pomegranate peel displayed higher growth (P < 0.05) and antioxidants with normal histology of the liver and spleen. Additionally, the intestinal villi length and goblet cells increased (P < 0.05) with increasing levels of biochar with the overexpression of the growth, antioxidant, and immune-related genes. The return parameters also showed the same trend, as the highest total return, net profit and rate of return on investment were recorded for fish-fed pomegranate peel-supplemented diets. Thus, pomegranate peel biochar could be considered a promising cost-effective supplement with the potential to improve Nile tilapia’s growth performance, antioxidant status, and economic feasibility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.